Positron Emission Tomography
GPTKB entity
Statements (53)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medical imaging technique
|
| gptkbp:abbreviation |
gptkb:PET
|
| gptkbp:assesses |
brain function
myocardial perfusion tumor metabolism |
| gptkbp:canBe |
research
brain mapping drug development clinical diagnosis treatment monitoring cardiac viability assessment infection imaging lymphoma staging inflammation imaging lung cancer diagnosis |
| gptkbp:category |
Nuclear medicine
|
| gptkbp:combines |
gptkb:computed_tomography
CT magnetic resonance imaging MRI |
| gptkbp:detects |
gptkb:gamma_rays
positron-emitting radionuclides coincidence events |
| gptkbp:developedBy |
1970s
|
| https://www.w3.org/2000/01/rdf-schema#label |
Positron Emission Tomography
|
| gptkbp:inventedBy |
gptkb:Edward_J._Hoffman
gptkb:Michael_E._Phelps |
| gptkbp:measures |
metabolic activity
|
| gptkbp:noninvasive |
true
|
| gptkbp:produces |
3D images
|
| gptkbp:provides |
molecular imaging
functional imaging |
| gptkbp:regulates |
gptkb:FDA
|
| gptkbp:requires |
cyclotron for tracer production
specialized equipment |
| gptkbp:used_in |
cardiology
neurology oncology |
| gptkbp:usedFor |
cancer diagnosis
cardiac imaging epilepsy evaluation Alzheimer's disease diagnosis Parkinson's disease assessment neurological studies heart disease assessment |
| gptkbp:uses |
radioactive tracers
short-lived isotopes |
| gptkbp:uses_principle |
annihilation of positrons
|
| gptkbp:uses_tracer |
gptkb:fluorodeoxyglucose_(FDG)
|
| gptkbp:bfsParent |
gptkb:Medical_Imaging
gptkb:Positron gptkb:PET_Scan |
| gptkbp:bfsLayer |
6
|